Legal Representation
Attorney
Margaret C. McHugh
USPTO Deadlines
Next Deadline
243 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-07-05)
Due Date
July 05, 2026
Grace Period Ends
January 05, 2027
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 5, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Feb 4, 2023 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Feb 4, 2023 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Feb 4, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 3, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 19, 2022 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jul 5, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Dec 2, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 5, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 2, 2016 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 1, 2016 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 17, 2016 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 12, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 13, 2016 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 13, 2016 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 13, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 18, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 18, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 29, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 16, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 1, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 24, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 22, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 22, 2015 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 22, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 14, 2015 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Apr 14, 2015 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 14, 2015 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 18, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 18, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 17, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 9, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 22, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 22, 2014 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 22, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 16, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 18, 2014 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Jun 17, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 7, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
First Use Anywhere:
Mar 31, 2015
First Use in Commerce:
Mar 31, 2015
Class 005
diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
First Use Anywhere:
Mar 31, 2015
First Use in Commerce:
Mar 31, 2015
Additional Information
Pseudo Mark
NK VIEW
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NK"